The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients. (Q53049216)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

positron emission tomography

1 reference

based on heuristic

inferred from title

B-cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

primary mediastinal B-cell lymphoma

1 reference

based on heuristic

inferred from title

Pier Luigi Zinzani

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Stefano A Pileri

9

object named as

Stefano Pileri

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Alessandro Broccoli

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Beatrice Casadei

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Vittorio Stefoni

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Cinzia Pellegrini

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Letizia Gandolfi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Roberto Maglie

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

25 September 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hematological Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

33

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

145-150

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

21 January 2018

Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

21 January 2018

Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

21 January 2018

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

21 January 2018

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

21 January 2018

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

21 January 2018

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

21 January 2018

Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

21 January 2018

MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

21 January 2018

Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

7 January 2021

based on heuristic

inferred from DOI database lookup

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2172

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HON.2172

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25256959%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53049216&oldid=1732878334"